Abstract
Sulfondiimines—the double aza-analogues of sulfones—hold significant potential as leads in discovery chemistry, yet their application in this arena has been held back by the scarcity of appropriate synthetic routes. Existing methods employ sulfides as substrates, and rely on consecutive imination reactions using the hazardous reagent O-mesitylenesulfonyl hydroxylamine. Here we report a method for sulfondiimine synthesis that does not begin with a sulfide or a thiol, and instead employs two Grignard reagents and a bespoke sulfinylamine (R—N=S=O) reagent as starting materials. Lewis acid-mediated assembly of these three components provides efficient access to a series of sulfilimine intermediates. A novel rhodium-catalyzed imination of these electron-rich sulfilimines then delivers a varied range of sulfondiimines featuring orthogonal N-functionalization. Conditions for the selective manipulation of both N-atoms of the sulfondiimines are reported, allowing access to a broad range of mono- and difunctionalized products. The oxidation of the sulfilimine intermediates is also described, and provides a complementary route to sulfoximines.
Sulfur(VI)-derived functional groups feature prominently in bioactive molecules, with sulfonamides and sulfones in particular being incorporated into many marketed pharmaceuticals and agrochemicals.1 The mono- and diaza analogues of these groups—sulfoximines, sulfondiimines and sulfonimidamides—are less prevalent; however, they too are emerging as useful functionalities in discovery chemistry (Figure 1a,b).2 For example, the commercial insecticide Sulfoxaflor features a sulfoximine group,3 as do several drug candidates that have been advanced to clinical trials.4 Additionally, the pharmaceutical industry is starting to populate the patent literature with examples of sulfonimidamide-containing molecules.5 Although sulfondiimines are the least represented member of this class, their attributes have also been recognized, with the result that they too are starting to feature in medicinal chemistry programs. Specific qualities associated with sulfondiimines include their heteroatom-rich nature, conferring both polarity and aqueous solubility, their three-dimensional topology, which is linked with the potential to “grow” the functional group along all 4-vertices from the central sulfur atom, and their potential to exist as single enantiomers.2a
Figure 1.
(a) Selected sulfur(VI) functional groups; (b) biologically relevant examples; (c) Bolm synthesis of sulfondiimines; (d) our modular synthesis of sulfondiimines.
The varying levels of uptake of these different aza-derivatives by the pharmaceutical and agrochemical industries can be broadly tracked to the advances achieved in the corresponding synthetic methods. For example, extensive studies from the Bolm laboratory,6 as well as others,7 have resulted in a variety of methods for sulfoximine preparation, with most routes usually starting from the corresponding sulfides or sulfoxides. Reports targeting sulfonimidamides are considerably fewer,8 although this has improved recently,9 while the only method for sulfondiimine preparation that reports more than a handful of select examples is the 2012 account from Bolm.10,11 The Bolm method employs sulfide substrates that are first converted to the corresponding N–H sulfilimine salts by treatment with O-mesitylenesulfonyl hydroxylamine (MSH), and then on to sulfondiimines by consecutive chlorination (N-chlorosuccinimide) and amine addition (Figure 1c). In this way, a broader range of sulfondiimines than had been previously accessible was obtained. Despite these advances, there remained several limitations; the sulfondiimines were obtained in generally modest yields, with the majority of examples featuring only an aryl group and a methyl group as the carbon-substituents at the sulfur center, with a single diaryl example being reported in poor yield. A single dialkyl-substituted example, derived from tetrahydrothiophene, was also reported. MSH is not an attractive reagent due to handling issues associated with its explosion risk. The use of sulfides, and therefore ultimately thiols, as substrates is a limitation due to their odorous nature and generally poorer commercial availability with respect to nonsulfur containing building blocks.
Motivated to deliver an enabling sulfondiimine synthesis capable of providing a broad range of substitution patterns, and to address the limitations of the existing methods, we embarked on the present study with the strategic decision to avoid the use of sulfides (and hence thiols) as starting materials. The resultant chemistry allows the modular assembly of sulfilimine intermediates from the combination of two Grignard reagents and a stable sulfinylamine reagent. Rhodium-catalyzed imination then provides a broad range of substituted sulfondiimines featuring orthogonal N-functionalization (Figure 1d).
To allow maximum flexibility for selective functionalization of the ultimate products, we targeted sulfondiimines with orthogonally functionalized N-atoms (Scheme 1a). Our immediate synthetic targets then became appropriately functionalized sulfilimines, although we were aware that the imination of N-functionalized sulfilimines to sulfondiimines had yet to be reported. In order to avoid the use of thiols, we envisioned an approach employing a central high-oxidation state sulfur linchpin to which functionalized carbon fragments could be sequentially attached (A → B → sulfilimine). A key simplifying element of our strategy, which avoids the need to prepare a sulfur fragment A with differentially reactive leaving groups, was to employ a sulfinylamine as the linchpin (Scheme 1b). The design of novel sulfinylamine 1, derived from readily available tert-octylamine, was based on the requirements of (i) reagent stability balanced with reactivity, (ii) a deprotectable N-substituent, and (iii) an electron-rich N-substituent to enable sulfilimine imination. These criteria ruled out the use of the commercial sulfinylamine TrNSO,9c,12 as well as known derivatives featuring electron-withdrawing N-substituents such as Ts or Cbz. Sulfinylamine 1 was conveniently prepared on multigram scale (Scheme 1c). The controlled consecutive addition of Grignard reagents to sulfinylamine 1 was achieved using Lewis acid activation (Scheme 1d). The optimal conditions involved addition of the initial Grignard reagent to sulfinylamine 1 and trimethylsilyl trifluoromethanesulfonate (TMS-OTf) at −78 °C for 1 min, before addition of the second Grignard reagent at −30 °C. Under these conditions sulfilimine 3a was obtained in an excellent 85% yield. Some flexibility for the temperature of the second addition was possible (entries 4–6, Scheme 1d).
Scheme 1. (a) Reaction Design; (b,c) Sulfinylamine Reagent 1; (d) Conditions for the Assembly of Sulfilimine 3a.
Ar1–MgBr (1.05 equiv), 1 (1.0 equiv), TMS-OTf (1.0 equiv), tetrahydrofuran (THF), −78 °C, 1 min, then Ar2–MgBr (1.5 equiv), −30 °C, 10 min. Isolated yields.
With access to the desired sulfilimines achieved, we turned our attention to their conversion into the corresponding sulfondiimines. Although many reagent and catalyst combinations have been reported for the imination of sulfoxides6,7,13 and sulfides,6a,14 the only effective imination of sulfilimines involved a two-stage chlorination/amine addition sequence, and was only successful on N–H sulfilimine substrates.10a,10b,11 The direct imination of N-alkyl sulfilimines is unknown. We elected to develop a metal-catalyzed imination process using iminoiodinane reagents, and chose sulfilimine 3b as our test substrate (Table 1). Exploratory reactions generating the iminoiodinanes in situ from iodosobenzene diacetate and nosylamide soon established that the significant basicity of the sulfilimine substrate, combined with the acetic acid produced during iminoiodinane formation, was problematic, even with the addition of excess base. Accordingly, we switched to the use of the preformed iminoiodinane, and found that when using Rh2(OAc)4 as a catalyst a modest yield of sulfondiimine 4b was obtained (entry 1). The addition of Na2CO3 and a move to Rh2(esp)2 as a catalyst15 significantly improved the yield (entries 2 and 3). Optimal conditions involved the use of 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) and 2.5 mol % of catalyst at 40 °C (entries 4–7). The use of iron- or copper-based catalysts was not effective (entries 8 and 9).
Table 1. Development of Conditions for the Preparation of Sulfondiimine 4ba.
| entry | catalyst | base | temp | yield of 4b |
|---|---|---|---|---|
| 1 | Rh2(OAc)4 (5 mol %) | – | 40 °C | 13% |
| 2 | Rh2(OAc)4 (5 mol %) | Na2CO3 | 40 °C | 40% |
| 3 | Rh2(esp)2 (5 mol %) | Na2CO3 | 40 °C | 80% |
| 4 | Rh2(esp)2 (5 mol %) | DBU | 40 °C | 84% |
| 5 | Rh2(esp)2 (2.5 mol %) | DBU | 40 °C | 88% |
| 6 | Rh2(esp)2 (2.5 mol %) | DBU | 22 °C | 82% |
| 7 | Rh2(esp)2 (0.5 mol %) | DBU | 40 °C | 78% |
| 8 | Fe(OTf)2 (10 mol %) | Na2CO3 | 40 °C | 0% |
| 9 | Cu(OTf)2 (10 mol %) | Na2CO3 | 40 °C | 0% |
3b (1.0 equiv), PhI = N–Ns (1.3 equiv), CH2Cl2, 24 h. Isolated yields.
Crucially, the optimized conditions for sulfilimine synthesis and for the imination of sulfilimines could be combined into a telescoped process to evaluate their application to sulfondiimine preparation (Table 2). In this way it was possible to avoid rigorous purification of the potentially sensitive sulfilimine intermediates, with an aqueous wash and extraction proving sufficient for most substrates. The more robust diarylsulfilimines were purified by flash chromatography. The sulfondiimine yields reported in Table 2 are for the two-stage procedure, with the initial Grignard reagent being the limiting component. A range of aryl Grignard reagents can be employed as the first organometallic reagent, followed by the addition of alkyl or aryl Grignard reagents, to provide sulfondiimines in respectable yields for this four-component two-stage assembly (4a–4h). These products are the first examples of orthogonally N-functionalized sulfondiimines prepared. The addition order can be reversed, with alkyl addition preceding aryl (4i). Organolithium reagents can also be used as nucleophiles (4j), providing greater flexibility in reagent choice, and allowing the introduction of a number of heteroaryl groups (4k–4m). The pyrazole-containing fragment incorporated into sulfondiimine 4n corresponds to the aryl unit of the marketed COX-2 inhibitor Celecoxib. The moderate yields obtained for several of the diaryl examples are the consequence of a slow imination step, with unreacted sulfilimine remaining in most cases.16
Table 2. Preparation of Sulfondiimines 4a.
R1–MgBr (1.0 equiv), 1 (1.05 equiv), TMS-OTf (1.0 equiv), THF, −78 °C, 1 min, then R2–MgBr (1.5 equiv), −30 °C, 10 min. Aqueous workup. PhI = N–Ns (1.3 equiv), [Rh2(esp)2] (2.5 mol %), CH2Cl2, 40 °C, 24 h. Isolated yields.
Total of 4.5 equiv of PhI = Ns used (1.5 × 3) and [Rh2(esp)2] (5.0 mol %), 60 °C, 24 h.
Organolithium used as 2nd nucleophile.
Using 2-methyl-1-propenylmagnesium bromide as 2nd organometallic reagent.
Dialkyl-substituted sulfondiimines were the most challenging class of products to obtain, and the low yields achieved reflect the instability of the sulfilimine intermediates, which were not purified and undergo a degree of decomposition during the imination step. Despite these difficulties a number of straight-chain alkyl, and cyclo-alkyl examples were obtained in low-modest yields (4o–4q). Unlike the precursor sulfilimines, the corresponding dialkyl sulfondiimines display good stability. The reaction could be scaled, with sulfondiimine 4b being obtained in 62% yield on a 10 mmol scale using only 0.5 mol % of the rhodium catalyst. The X-ray structures of sulfondiimines 4a, 4b, and 4p shown in Table 2 provide a compelling graphical representation of the hindered environments around the fully substituted tetrahedral sulfur-centers in these molecules.
The ready preparation of a broad range of sulfilimines provided an opportunity to deliver a complementary route to sulfoximines, which would again avoid the use of thiols and sulfides as starting materials. As before, the optimal procedure involved a two-stage operation with the second stage now being sulfilimine oxidation, achieved using catalytic tetra-propylammonium perruthenate (TPAP) and N-methylmorpholine N-oxide (NMO).
The yields given for the individual examples are based on the initial Grignard reagent as the limiting substrate. Using this method a broad range of aryl–alkyl (5a–c) and aryl–aryl (5d–5j) substituted sulfoximines were obtained in high yields (Table 3). Included in the aryl–aryl examples are the three regioisomeric tolyl derivatives (5g–5i), demonstrating that sterically demanding ortho-substituents can be tolerated. Heteroaryl groups can also be installed efficiently using this approach (5k,l). As with the corresponding sulfondiimine examples, dialkyl sulfoximines were challenging to prepare, with sulfoximines 5m and 5n being representative. The final example in Table 3 includes the complex aryl unit of the COX-2 inhibitor Celecoxib (5o).
Table 3. Preparation of Sulfoximines 5a.
R1-MgBr (1.0 equiv), 1 (1.05 equiv), TMS-OTf (1.0 equiv), THF, −78 °C, 1 min, then R2-MgBr (1.5 equiv), −30 °C, 10 min. Aqueous workup. TPAP (5 mol %), NMO (6.0 equiv), MeCN, 40 °C. Isolated yields.
Organolithium used as 2nd nucleophile.
50 °C for 2nd step.
TPAP (15 mol %).
Using 2-methyl-1-propenylmagnesium bromide as 2nd organometallic reagent.
Returning to sulfondiimines, in addition to developing a synthesis capable of broad variation of the carbon-based groups attached at sulfur, we also wanted to allow maximum flexibility for N-functionalization. Our choice of tert-octyl and nosyl groups as N-substituents allowed orthogonal deprotection of these groups in high yields. For example, the N-tert-octyl group of sulfondiimine 4b could be removed by simple treatment with TFA, providing N–H sulfondiimine 6 in high yield (Scheme 2). The N-nosyl group of 4b was removed by treatment with dodecanethiol and DBU, providing N–H sulfondiimine 7 in 89% yield. The double N–H sulfondiimine 8 was available in excellent yield from Ns-derivative 6. Additionally, the t-Oct group of sulfilimine 3a was readily cleaved to provide the corresponding N–H derivative 9 in 97% yield. Similarly, N–H sulfoximine 10 was available efficiently from the corresponding N-t-Oct derivative.
Scheme 2. N-tert-Octyl and N-Nosyl Deprotection.
The ability to selectively unveil an N–H group in the presence of a second orthogonally protected N-atom allowed for the preparation of a diverse range of N-derivatives. The complementary electronic character of the two N-protecting groups was key to achieving efficient reactions. For example, the electron-withdrawing ability of the nosyl group in sulfondiimine 6 allowed efficient N-arylation under Chan-Lam conditions,17 as well as allylation using KOH and allyl bromide,11 providing sulfondiimines 11 and 12, respectively, following Ns cleavage (Scheme 3). Conversely, the electron-rich N-tert-octyl derivative 7 was converted to N-acyl derivative 13, urea 14, and N-benzyl derivative 15, all after N-tert-octyl cleavage. Benzyl derivative 15 was obtained using a reductive amination procedure, a transformation reported here for the first time on a sulfondiimine.
Scheme 3. N-Functionalization of Sulfondiimines 6 and 7.
In conclusion, we have developed a modular sulfondiimine synthesis from the combination of two organometallic reagents and a sulfinylamine linker, followed by a novel S-imination. The need to use malodorous and air-sensitive thiols is avoided. Alkyl, aryl, and heteroaryl S-substituents can all be introduced. The presence of orthogonal N-substituents allows the use of a diverse range of N-functionalization reactions. Taken together, these features have allowed the preparation of the most diverse set of sulfondiimines yet reported. We anticipate that the scope and flexibility of the developed chemistry will lead to further applications of sulfondiimines in discovery chemistry.
Acknowledgments
The China Scholarship Council (to Z.-X.Z.) and the EPSRC Centre for Doctoral Training in Synthesis for Biology and Medicine (EP/L015838/1, to T.Q.D.) are thanked for their support of this study. Antoine de Gombert and Richard Cooper (both Oxford) are thanked for X-ray structure analysis.
Supporting Information Available
The Supporting Information is available free of charge on the ACS Publications website at DOI: 10.1021/jacs.9b06831.
The authors declare no competing financial interest.
Supplementary Material
References
- a Scott K. A.; Njardarson J. T. Analysis of US FDA-Approved Drugs Containing Sulfur Atoms. Top Curr. Chem. 2018, 376, 5. 10.1007/s41061-018-0184-5. [DOI] [PubMed] [Google Scholar]; b Feng M. H.; Tang B. Q.; Liang S. H.; Jiang X. F. Sulfur Containing Scaffolds in Drugs: Synthesis and Application in Medicinal Chemistry. Curr. Top. Med. Chem. 2016, 16, 1200–1216. 10.2174/1568026615666150915111741. [DOI] [PMC free article] [PubMed] [Google Scholar]
- a Lücking U. Neglected Sulfur(VI) Pharmacophores in Drug Discovery: Exploration of Novel Chemical Space by the Interplay of Drug Design and Method Development. Org. Chem. Front. 2019, 6, 1319–1324. 10.1039/C8QO01233D. [DOI] [Google Scholar]; b Chinthakindi P. K.; Naicker T.; Thota N.; Govender T.; Kruger H. G.; Arvidsson P. I. Sulfonimidamides in Medicinal and Agricultural Chemistry. Angew. Chem., Int. Ed. 2017, 56, 4100–4109. 10.1002/anie.201610456. [DOI] [PubMed] [Google Scholar]; c Lücking U. Sulfoximines: A Neglected Opportunity in Medicinal Chemistry. Angew. Chem., Int. Ed. 2013, 52, 9399–9408. 10.1002/anie.201302209. [DOI] [PubMed] [Google Scholar]; d Frings M.; Bolm C.; Blum A.; Gnamm C. Sulfoximines from a Medicinal Chemist’s Perspective: Physicochemical and in vitro Parameters Relevant for Drug Discovery. Eur. J. Med. Chem. 2017, 126, 225–245. 10.1016/j.ejmech.2016.09.091. [DOI] [PubMed] [Google Scholar]
- Zhu Y.; Loso M. R.; Watson G. B.; Sparks T. C.; Rogers R. B.; Huang J. X.; Gerwick B. C.; Babcock J. M.; Kelley D.; Hegde V. B.; Nugent B. M.; Renga J. M.; Denholm I.; Gorman K.; DeBoer G. J.; Hasler J.; Meade T.; Thomas J. D. Discovery and Characterization of Sulfoxaflor, a Novel Insecticide Targeting Sap-Feeding Pests. J. Agric. Food Chem. 2011, 59, 2950–7. 10.1021/jf102765x. [DOI] [PubMed] [Google Scholar]
- a Lücking U.; Jautelat R.; Krüger M.; Brumby T.; Lienau P.; Schäfer M.; Briem H.; Schulze J.; Hillisch A.; Reichel A.; Wengner A. M.; Siemeister G. The Lab Oddity Prevails: Discovery of Pan-CDK Inhibitor (R)-S-Cyclopropyl-S-(4-{[4-{[(1R,2R)-2-hydroxy-1-methylpropyl]oxy}-5-(trifluoromethyl)pyrimidin-2-yl]amino}phenyl)sulfoximide (BAY1000394) for the Treatment of Cancer. ChemMedChem 2013, 8, 1067–1085. 10.1002/cmdc.201300096. [DOI] [PubMed] [Google Scholar]; b Lücking U.; Scholz A.; Lienau P.; Siemeister G.; Kosemund D.; Bohlmann R.; Briem H.; Terebesi I.; Meyer K.; Prelle K.; Denner K.; Bömer U.; Schäfer M.; Eis K.; Valencia R.; Ince S.; von Nussbaum F.; Mumberg D.; Ziegelbauer K.; Klebl B.; Choidas A.; Nussbaumer P.; Baumann M.; Schultz-Fademrecht C.; Rühter G.; Eickhoff J.; Brands M. Identification of Atuveciclib (BAY 1143572), the First Highly Selective, Clinical PTEFb/CDK9 Inhibitor for the Treatment of Cancer. ChemMedChem 2017, 12, 1776–1793. 10.1002/cmdc.201700447. [DOI] [PMC free article] [PubMed] [Google Scholar]; c Vendetti F. P.; Lau A.; Schamus S.; Conrads T. P.; O’Connor M. J.; Bakkenist C. J. The Orally Active and Bioavailable ATR Kinase Inhibitor AZD6738 Potentiates the Anti-Tumor Effects of Cisplatin to Resolve ATM-Deficient Non-Small Cell Lung Cancer in vivo. Oncotarget 2015, 6, 44289–44305. 10.18632/oncotarget.6247. [DOI] [PMC free article] [PubMed] [Google Scholar]; d Nishimura N.; Norman M. H.; Liu L.; Yang K. C.; Ashton K. S.; Bartberger M. D.; Chmait S.; Chen J.; Cupples R.; Fotsch C.; Helmering J.; Jordan S. R.; Kunz R. K.; Pennington L. D.; Poon S. F.; Siegmund A.; Sivits G.; Lloyd D. J.; Hale C.; St Jean D. J. Jr. Small Molecule Disruptors of the Glucokinase-Glucokinase Regulatory Protein Interaction: 3. Structure-Activity Relationships Within the Aryl Carbinol Region of the N-Arylsulfonamido-N’-Arylpiperazine Series. J. Med. Chem. 2014, 57, 3094–116. 10.1021/jm5000497. [DOI] [PubMed] [Google Scholar]
- a Miller D.; Thom S.; St-Galley S.; Shannon J.; Leeson P.. Novel Compounds. Patent WO2019/068772A1, 2019.; b Biftu T.; Khan T. A.. Treating Diabetes with Dipeptidyl Peptidase-IV Inhibitors. Patent WO2014018355A1, 2014.
- a Bizet V.; Hendriks C. M. M.; Bolm C. Sulfur Imidations: Access to Sulfimides and Sulfoximines. Chem. Soc. Rev. 2015, 44, 3378–3390. 10.1039/C5CS00208G. [DOI] [PubMed] [Google Scholar]; b Okamura H.; Bolm C. Sulfoximines: Synthesis and Catalytic Applications. Chem. Lett. 2004, 33, 482–487. 10.1246/cl.2004.482. [DOI] [Google Scholar]; c Steinkamp A. D.; Wiezorek S.; Brosge F.; Bolm C. Building Block Approach for the Synthesis of Sulfoximines. Org. Lett. 2016, 18, 5348–5351. 10.1021/acs.orglett.6b02678. [DOI] [PubMed] [Google Scholar]; d Yu H.; Li Z.; Bolm C. Three-Dimensional Heterocycles by Iron-Catalyzed Ring-Closing Sulfoxide Imidation. Angew. Chem., Int. Ed. 2018, 57, 12053–12056. 10.1002/anie.201804284. [DOI] [PubMed] [Google Scholar]; e Yu H.; Li Z.; Bolm C. Iron(II)-Catalyzed Direct Synthesis of NH Sulfoximines from Sulfoxides. Angew. Chem., Int. Ed. 2018, 57, 324–327. 10.1002/anie.201710498. [DOI] [PubMed] [Google Scholar]
- a Luisi R.; Bull J.; Degennaro L. Straightforward Strategies for the Preparation of NH-Sulfoximines: A Serendipitous Story. Synlett 2017, 28, 2525–2538. 10.1055/s-0036-1590874. [DOI] [Google Scholar]; b Tota A.; Zenzola M.; Chawner S. J.; John-Campbell S. S.; Carlucci C.; Romanazzi G.; Degennaro L.; Bull J. A.; Luisi R. Synthesis of NH-Sulfoximines from Sulfides by Chemoselective One-Pot N- and O-Transfers. Chem. Commun. 2017, 53, 348–351. 10.1039/C6CC08891K. [DOI] [PubMed] [Google Scholar]; c Zenzola M.; Doran R.; Degennaro L.; Luisi R.; Bull J. A. Transfer of Electrophilic NH Using Convenient Sources of Ammonia: Direct Synthesis of NH Sulfoximines from Sulfoxides. Angew. Chem., Int. Ed. 2016, 55, 7203–7207. 10.1002/anie.201602320. [DOI] [PMC free article] [PubMed] [Google Scholar]; d Reboul V.; Glachet T.; Franck X. Late-Stage Sulfoximination: Improved Synthesis of the Anticancer Drug Candidate Atuveciclib. Synthesis 2019, 51, 971–975. 10.1055/s-0037-1610316. [DOI] [Google Scholar]; e Chaabouni S.; Lohier J. F.; Barthelemy A. L.; Glachet T.; Anselmi E.; Dagousset G.; Diter P.; Pegot B.; Magnier E.; Reboul V. One-Pot Synthesis of Aryl- and Alkyl S-Perfluoroalkylated NH-Sulfoximines from Sulfides. Chem. - Eur. J. 2018, 24, 17006–17010. 10.1002/chem.201805055. [DOI] [PubMed] [Google Scholar]; f Lohier J.-F.; Glachet T.; Marzag H.; Gaumont A.-C.; Reboul V. Mechanistic Investigation of the NH-Sulfoximination of Sulfide. Evidence for λ6-Sulfanenitrile Intermediates. Chem. Commun. 2017, 53, 2064–2067. 10.1039/C6CC09940H. [DOI] [PubMed] [Google Scholar]; g Goldberg F. W.; Kettle J. G.; Xiong J.; Lin D. General Synthetic Strategies Towards N-Alkyl Sulfoximine Building Blocks for Medicinal Chemistry and the Use of Dimethylsulfoximine as a Versatile Precursor. Tetrahedron 2014, 70, 6613–6622. 10.1016/j.tet.2014.06.120. [DOI] [Google Scholar]; h Matos P. M.; Lewis W.; Moore J. C.; Stockman R. A. Sulfonimidates: Useful Synthetic Intermediates for Sulfoximine Synthesis via C-S Bond Formation. Org. Lett. 2018, 20, 3674–3677. 10.1021/acs.orglett.8b01473. [DOI] [PubMed] [Google Scholar]
- a Nandi G. C.; Kota S. R.; Govender T.; Kruger H. G.; Arvidsson P. I. Cu(OAc)2 Promoted Chan–Evans–Lam C–N Cross Coupling Reactions on the N- and N′-Nitrogen Atoms of Sulfonimidamides with Aryl Boronic Acids. Tetrahedron 2014, 70, 5428–5433. 10.1016/j.tet.2014.06.122. [DOI] [Google Scholar]; b Funes Maldonado M.; Sehgelmeble F.; Bjarnemark F.; Svensson M.; Åhman J.; Arvidsson P. I. Synthesis and Arylation of Unprotected Sulfonimidamides. Tetrahedron 2012, 68, 7456–7462. 10.1016/j.tet.2012.06.072. [DOI] [Google Scholar]; c Garcia Mancheño O.; Bolm C. Synthesis of Sulfonimidamides from Sulfinamides by Oxidation With N-Chlorosuccinimide. Beilstein J. Org. Chem. 2007, 3, 25. 10.1186/1860-5397-3-25. [DOI] [PMC free article] [PubMed] [Google Scholar]; d Johnson C. R.; Jonsson E. U.; Bacon C. C. Preparation and Reactions of Sulfonimidoyl Chlorides. J. Org. Chem. 1979, 44, 2055–2061. 10.1021/jo01327a001. [DOI] [Google Scholar]
- a Izzo F.; Schafer M.; Lienau P.; Ganzer U.; Stockman R.; Lucking U. Exploration of Novel Chemical Space: Synthesis and in vitro Evaluation of N-Functionalized Tertiary Sulfonimidamides. Chem. - Eur. J. 2018, 24, 9295–9304. 10.1002/chem.201801557. [DOI] [PMC free article] [PubMed] [Google Scholar]; b Izzo F.; Schafer M.; Stockman R.; Lucking U. A New, Practical One-Pot Synthesis of Unprotected Sulfonimidamides by Transfer of Electrophilic NH to Sulfinamides. Chem. - Eur. J. 2017, 23, 15189–15193. 10.1002/chem.201703272. [DOI] [PMC free article] [PubMed] [Google Scholar]; c Davies T. Q.; Hall A.; Willis M. C. One-Pot, Three-Component Sulfonimidamide Synthesis Exploiting the Sulfinylamine Reagent N-Sulfinyltritylamine, TrNSO. Angew. Chem., Int. Ed. 2017, 56, 14937–14941. 10.1002/anie.201708590. [DOI] [PubMed] [Google Scholar]; d Wen J.; Cheng H.; Dong S.; Bolm C. Copper-Catalyzed S-C/S-N Bond Interconversions. Chem. - Eur. J. 2016, 22, 5547–50. 10.1002/chem.201600661. [DOI] [PubMed] [Google Scholar]; e Richards-Taylor C. S.; Martinez-Lamenca C.; Leenaerts J. E.; Trabanco A. A.; Oehlrich D. The Synthesis of Trifluoromethyl-Sulfonimidamides from Sulfinamides. J. Org. Chem. 2017, 82, 9898–9904. 10.1021/acs.joc.7b01628. [DOI] [PubMed] [Google Scholar]; f Wright M.; Martinez-Lamenca C.; Leenaerts J. E.; Brennan P. E.; Trabanco A. A.; Oehlrich D. Bench-Stable Transfer Reagent Facilitates the Generation of Trifluoromethyl-sulfonimidamides. J. Org. Chem. 2018, 83, 9510–9516. 10.1021/acs.joc.8b01244. [DOI] [PubMed] [Google Scholar]; g Chen Y.; Gibson J. A Convenient Synthetic Route to Sulfonimidamides from Sulfonamides. RSC Adv. 2015, 5, 4171–4174. 10.1039/C4RA14056G. [DOI] [Google Scholar]
- a Furukawa N.; Akutagawa K.; Yoshimura T.; Akasaka T.; Oae S. A Modified Synthesis of Diaryl Sulfone Diimides. Synthesis 1979, 1979, 289–290. 10.1055/s-1979-28651. [DOI] [Google Scholar]; b Georg G.; Haake M. A New Method for the Synthesis of Diaryl Sulfone Diimides and sec-Alkyl Aryl Sulfone Diimides. Synthesis 1983, 1983, 919. 10.1055/s-1983-30568. [DOI] [Google Scholar]; c Yoshimura T.; Kita H.; Takeuchi K.; Takata E.; Hasegawa K.; Shimasaki C.; Tsukurimichi E. First Preparation and Reactions of S,S-Diaryl-S-fluorothiazynes, Ar2SF(N). Chem. Lett. 1992, 21, 1433–1436. 10.1246/cl.1992.1433. [DOI] [Google Scholar]; d Haake M. Ein Neues Verfahren zur Darstellung von S,S-Dialkylschwefeldiimiden. Tetrahedron Lett. 1970, 11, 4449–4450. 10.1016/S0040-4039(01)83947-2. [DOI] [Google Scholar]
- Candy M.; Guyon C.; Mersmann S.; Chen J. R.; Bolm C. Synthesis of Sulfondiimines by N-Chlorosuccinimide-Mediated Oxidative Imination of Sulfiliminium Salts. Angew. Chem., Int. Ed. 2012, 51, 4440–3. 10.1002/anie.201201296. [DOI] [PubMed] [Google Scholar]
- The TrNSO reagent was poorly reactive in the present system, and this was attributed to the steric bulk of the trityl-group hindering addition of the second nucleophile.
- Hendriks C. M. M.; Lamers P.; Engel J.; Bolm C. Sulfoxide-to-Sulfilimine Conversions: Use of Modified Burgess-Type Reagents. Adv. Synth. Catal. 2013, 355, 3363–3368. 10.1002/adsc.201300766. [DOI] [Google Scholar]
- a Lebel H.; Piras H.; Bartholomeus J. Rhodium-Catalyzed Stereoselective Amination of Thioethers with N-Mesyloxycarbamates: DMAP and bis(DMAP)CH(2)Cl(2) as Key Sdditives. Angew. Chem., Int. Ed. 2014, 53, 7300–4. 10.1002/anie.201402961. [DOI] [PubMed] [Google Scholar]; b Lebel H.; Piras H. Stereoselective Synthesis of Chiral Sulfilimines from N-Mesyloxycarbamates: Metal-Nitrenes versus Metal-Nitrenoids Species. J. Org. Chem. 2015, 80, 3572–85. 10.1021/acs.joc.5b00256. [DOI] [PubMed] [Google Scholar]
- Espino C. G.; Fiori K. W.; Kim M.; Du Bois J. Expanding the Scope of C–H Amination through Catalyst Design. J. Am. Chem. Soc. 2004, 126, 15378–15379. 10.1021/ja0446294. [DOI] [PubMed] [Google Scholar]
- Sulfondiimine 4h is indicative: The required sulfilimine intermediate (3h) was isolated in 89% yield, with the imination proceeding in 33% yield. The mass balance was made up of unreacted sulfilimine.
- Vantourout J. C.; Li L.; Bendito-Moll E.; Chabbra S.; Arrington K.; Bode B. E.; Isidro-Llobet A.; Kowalski J. A.; Nilson M. G.; Wheelhouse K. M. P.; Woodard J. L.; Xie S.; Leitch D. C.; Watson A. J. B. Mechanistic Insight Enables Practical, Scalable, Room Temperature Chan–Lam N-Arylation of N-Aryl Sulfonamides. ACS Catal. 2018, 8, 9560–9566. 10.1021/acscatal.8b03238. [DOI] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.








